Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Shares Outstanding (2016 - 2025)

Immucell's Shares Outstanding history spans 16 years, with the latest figure at $9.1 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 0.7% year-over-year to $9.1 million; the TTM value through Dec 2025 reached $9.1 million, up 0.7%, while the annual FY2025 figure was $9.1 million, 0.7% up from the prior year.
  • Shares Outstanding reached $9.1 million in Q4 2025 per ICCC's latest filing, roughly flat from $9.1 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $9.1 million in Q2 2025 to a low of $67301.0 in Q4 2022.
  • Average Shares Outstanding over 5 years is $7.0 million, with a median of $7.8 million recorded in 2021.
  • Peak YoY movement for Shares Outstanding: tumbled 99.14% in 2023, then soared 13118.82% in 2024.
  • A 5-year view of Shares Outstanding shows it stood at $72301.0 in 2021, then fell by 6.92% to $67301.0 in 2022, then skyrocketed by 11510.77% to $7.8 million in 2023, then grew by 15.72% to $9.0 million in 2024, then rose by 0.7% to $9.1 million in 2025.
  • Per Business Quant, the three most recent readings for ICCC's Shares Outstanding are $9.1 million (Q4 2025), $9.1 million (Q3 2025), and $9.1 million (Q2 2025).